| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |